Your session is about to expire
← Back to Search
Caregiver SOS Program for Caregiver Stress (Caregiver SOS Trial)
Caregiver SOS Trial Summary
This trial is testing whether a program that helps caregivers manage their stress will improve the caregivers' wellbeing, work functioning, and the quality of care for the person they are caring for.
Caregiver SOS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCaregiver SOS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Caregiver SOS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am a veteran or caregiver and I am 18 years old or older.I am a veteran diagnosed with depression, anxiety, PTSD, or TBI.I help a Veteran with daily tasks like shopping, finances, and health management.I am willing and able to give my consent for treatment.
- Group 1: Caregiver SOS
- Group 2: Usual Care
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the maximum capacity of participants for this research endeavor?
"Affirmative, according to clinicaltrials.gov the trial is presently recruiting participants. The posting of this study was originally on December 28th 2020 and it has been recently modified as of November 16th 2022. 300 individuals need to be recruited from 2 medical centres."
Are there any open enrolment slots for this clinical investigation?
"This medical study is actively enrolling participants. It was initially posted on December 28th 2020, and the details were recently updated on November 16th 2022 according to clinicaltrials.gov."
Share this study with friends
Copy Link
Messenger